Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Cancer Research
|
October 1, 1988
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage
J K Willson, P H Fischer, K Tutsch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 1998
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group
T J Smith, L M Ryan, H O Douglass, et al.
Breast Cancer Research and Treatment
|
October 1, 1993
High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group)
K W Gilchrist, R Gray, A M van Driel-Kulker, et al.
Cancer
|
January 15, 1994
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen
K E Gale, J W Andersen, D C Tormey, et al.
Cancer Chemotherapy Reports
|
November 1, 1975
Urinary excretion of polyamines by patients with advanced malignancy
T P Waalkes, C W Gehrke, D C Tormey, et al.
American Journal of Clinical Oncology
|
June 1, 1984
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study
D C Tormey, V E Weinberg, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma
D C Allred, G M Clark, A K Tandon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group
A Recht, R Gray, N E Davidson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1983
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer
D C Tormey, V E Weinberg, J F Holland, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)
L G Dressler, L Eudey, R Gray, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Cancer Research
|
October 1, 1988
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage
J K Willson, P H Fischer, K Tutsch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 1998
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group
T J Smith, L M Ryan, H O Douglass, et al.
Breast Cancer Research and Treatment
|
October 1, 1993
High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group)
K W Gilchrist, R Gray, A M van Driel-Kulker, et al.
Cancer
|
January 15, 1994
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen
K E Gale, J W Andersen, D C Tormey, et al.
Cancer Chemotherapy Reports
|
November 1, 1975
Urinary excretion of polyamines by patients with advanced malignancy
T P Waalkes, C W Gehrke, D C Tormey, et al.
American Journal of Clinical Oncology
|
June 1, 1984
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study
D C Tormey, V E Weinberg, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma
D C Allred, G M Clark, A K Tandon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group
A Recht, R Gray, N E Davidson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1983
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer
D C Tormey, V E Weinberg, J F Holland, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)
L G Dressler, L Eudey, R Gray, et al.
Page
of 14